Treatment of Adriamycin, a type of chemotherapy, may be linked with breast cancer in Hodgkin lymphoma survivors, a study showed. Survivors of Hodgkin lymphoma who have received Adriamycin (doxorubicin ...

After the publication of the 10-year survival data from Milan on the adjuvant use of the block sequential regimen consisting of four cycles of adriamycin followed by eight cycles of intravenous CMF, ...

The breast cancer drug Herceptin prevents breast cancer from coming back in some women, new research shows. Moreover, Herceptin works just as well with and without Adriamycin, a chemotherapy drug ...

The effect of adriamycin in combination with radiation on the skin reactions of mouse feet has been examined under a variety of experimental conditions including: (a) Hyperthermic treatment (42.8°C, 1 ...

Effect of circulating tumor cells distribution in treatment naive and treated patients with advance stage breast cancer on disease burden. Amelioration of acute radiation dermatitis in patients with ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window I'm Dr. Mark ...

Doxorubicin (Adriamycin (50 mg)) is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.It works by killing cancer cells. The information provided on this page is ...

Review the side-effects of Doxorubicin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up. This is an ASCO Meeting Abstract ...

This trial looked at a combination of bortezomib, adriamycin and dexamethasone (PAD) for myeloma. It was for people who had not had any other treatment for their myeloma. The trial was open for people ...

AMORY – In the years since she was 45, not only has Brenda Boozer earned the designation of being a breast cancer survivor, she has used the experience as motivation to defeat Stage 3 lymphoma and ...